InvestorsHub Logo
Followers 9
Posts 180
Boards Moderated 0
Alias Born 02/10/2014

Re: None

Monday, 12/15/2014 8:13:24 AM

Monday, December 15, 2014 8:13:24 AM

Post# of 15799
OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)

hGH-CTP in global clinical development for the treatment of pediatric and adult growth hormone deficiency (GHD)
hGH-CTP has potential to reduce dosing frequency of human growth hormone to single weekly injection from current standard of daily injection
OPKO to receive upfront payment of $295 million and eligible to receive up to an additional $275 million upon achievement of regulatory milestones
Upon Pfizer’s commercialization of hGH-CTP, OPKO is eligible to receive royalty and/or profit sharing payments
Pfizer to obtain exclusive license to commercialize hGH-CTP globally
http://finance.yahoo.com/news/opko-pfizer-enter-global-agreement-130000473.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News